Last reviewed · How we verify
NCT04565444
Ketones and Muscle Protein Synthesis
NA trial testing Ketone in Ketosis in 36 participants. Completed in 14 May 2021.
14 May 2021
Quick facts
| Lead sponsor | McGill University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 21 September 2020 |
| Primary completion | 14 May 2021 |
| Estimated completion | 14 May 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Ketone — full drug profile →
- Ketone + Protein
- Protein
Conditions studied
- Ketosis — all drugs for Ketosis →
- Regulation of Muscle Protein Synthesis — all drugs for Regulation of Muscle Protein Synthesis →
Sponsor
McGill University
Who can join
Adults 18 to 35, male only, with Ketosis or Regulation of Muscle Protein Synthesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ketones are natural substances normally produced by the body during prolonged fasting and starvation, or in response to a "ketogenic" diet to be used as fuel by the brain and muscles. Ketones are therefore similar to dietary proteins, carbohydrates and fats since they represent a source of energy for the body. In addition to serving as a source of energy, ketones have also been shown to stimulate increased rates of muscle protein synthesis in humans. The ingestion of dietary protein is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle. The rate of muscle protein synthesis can be maximized following the intake of 20g of protein. As a result, smaller doses of protein (i.e. 10g) represent a sub-optimal dose of protein because there is still room for improvement concerning muscle protein synthesis. Recently ketone-containing food products have become available that elevate ketone levels in the body without the need for ketogenic diets or prolonged fasting. Therefore, the purpose of this study is to measure skeletal muscle protein synthesis rates after ingesting the following: 1. Ketone monoester 2. Ketone monoester supplemented with sub-optimal dose of whey protein 3. Sub-optimal dose of whey protein It is hypothesized that muscle protein synthesis rates will increase following the ingestion of a ketone-containing beverage. Further, muscle protein synthesis rates will be enhanced when the ketone-containing beverage and sub-optimal protein dose are taken together.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Acute ingestion of a ketone monoester, whey protein, or their co-ingestion in the overnight postabsorptive state elicit a similar stimulation of myofibrillar protein synthesis rates in young males: a double-blind randomized trial.
Hannaian SJ, Lov J, Hawley SE, Dargegen M, et al · · 2024 · cited 8× · PMID 38215886 · DOI 10.1016/j.ajcnut.2024.01.004 -
Acute effects of a ketone monoester, whey protein, or their coingestion on mTOR trafficking and protein-protein colocalization in human skeletal muscle.
Hannaian SJ, Lov J, Cheng-Boivin Z, Abou Sawan S, et al · · 2024 · cited 6× · PMID 38682238 · DOI 10.1152/ajpcell.00207.2024
Verify or expand the search:
- PubMed search for NCT04565444
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ketone
Trials testing the same drug.
- NCT05118061 — StatStrip Glucose/Ketone Meter System Ketone Evaluation · completed
- NCT04079907 — Ketone Supplementation in Adolescents Post-Concussion · NA · completed
Other recruiting trials for Ketosis
Currently open trials in the same condition.
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06338969 — The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis · NA · recruiting
- NCT05924295 — Variations in Ketone Metabolism · NA · recruiting
Other McGill University trials
Trials by the same sponsor.
- NCT07178535 — Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke · NA · not yet recruiting
- NCT07445841 — Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training · NA · recruiting
- NCT07447830 — The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Stud · NA · recruiting
- NCT07497425 — Neuroimmune Responses to Exercise in Chronic Back Pain · NA · recruiting
- NCT06994559 — Music as an Adjunct to Ketamine Therapy for Chronic Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04565444 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McGill University
- Last refreshed: 18 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04565444.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing